ONC Stock Analysis: Buy, Sell, or Hold?
ONC - BeOne Medicines Ltd. American Depositary Shares
$340.38
-9.62 (-2.75%)
▼
BUY
HIGH Confidence
Last Updated: January 30, 2026
Earnings: Feb 26, 2026
26d
Get Alerted When ONC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
🚀 STRONG BUY: ONC shows excellent value with unusually cheap options (IV 9th percentile) and market pricing in only 1.1% annual growth despite strong fundamentals. High conviction opportunity.
🚀 STRONG BUY: ONC shows excellent value with unusually cheap options (IV 9th percentile) and market pricing in only 1.1% annual growth despite strong fundamentals. High conviction opportunity.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$308.72
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$191.69
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ONC is currently trading at $340.38, which is considered slightly high relative to its 30-day fair value range of $314.64 to $343.94. The stock's valuation (Forward PE: 55.2) is in line with its historical norms (53.4). At these levels, the market is pricing in 1.1% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, ONC is showing sideways momentum. Immediate support is located at $325.10, while resistance sits at $353.00.
Market Sentiment: ONC has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (9th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $404.19 (+15.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ONC is showing sideways momentum. Immediate support is located at $325.10, while resistance sits at $353.00.
Market Sentiment: ONC has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (9th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $404.19 (+15.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Fair Price Range
$314.64 -
$343.94
Company Quality Score
63/100
(BUY)
Options IV Signal
9th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
79.6%
All Signals
- BULLISH: Options cheap (IV 9th percentile)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($404.19)
- NEUTRAL: Market pricing in 1.1% annual earnings growth - fairly valued
Fair Price Analysis
30-Day Fair Range
$314.64 -
$343.94
Current vs Fair Value
SLIGHTLY HIGH
Expected Move (7 Days)
±$22.26
(6.5%)
Support & Resistance Levels
Support Level
$325.10
Resistance Level
$353.00
Current Trend
Sideways
Fundamental Context
Forward P/E (Next Year Est.)
55.19
Wall Street Target
$404.19
(+15.5%)
Revenue Growth (YoY)
41.0%
Profit Margin
1.4%
Valuation Premium vs History
+1.1% premium
PE vs Historical
55.2 vs 53.4
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+1.1%
(market-implied from PE analysis)
1-Year Target
$353.85
(+1%)
2-Year Target
$357.74
(+2%)
3-Year Target
$361.68
(+3%)
3-Yr Target (if PE normalizes)
(PE: 55→53)
PE COMPRESSION
$349.92
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 55.2, Growth: 85.8%)
$1181.25
(+238%)
Base:
(SPY PE: 22.3, Growth: 85.8%)
$477.26
(+36%)
Bear:
(PE: 19.0, Growth: 85.8%)
$405.67
(+16%)
📈
Valuation based on Current Earnings
Forward PE: 41.32 | Forward EPS (Implied): $8.47
Bull Case
$422.63
(+21%)
Analyst growth 15.0%, PE expands to 43.4
Base Case
$350.00
(0%)
Market implied 0.0%, PE stable at 41.3
Bear Case
$267.75
(-24%)
Severe decline -15.0%, PE contracts to 37.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Last updated: January 30, 2026 4:12 PM ET
Data refreshes hourly during market hours. Next update: 5:12 PM
Data refreshes hourly during market hours. Next update: 5:12 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ONC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
9
Sells
Net
INSIDERS SELLING
Recent Transactions
Chan Henry Lee
SELL
10671 shares
2025-10-08
John Oyler
SELL
27803 shares
2025-09-16
Chan Henry Lee
SELL
10006 shares
2025-09-10
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$91 | 59 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1035 | 58 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 60 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$117 | 59 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$141 | 59 HOLD |
Advanced ONC Option Strategies
Professional options setups generated by AI based on today's ONC price and gamma walls.